Skip to main content

Table 7 Clinical characteristics of CRC in different sites from Broad Institute’s GDAC Firehose

From: Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer

  Rectum group Colon group p-value
Cases, n 41 176
Males, n 24 93 0.510
Age (years) 44.88 ± 14.26 43.90 ± 14.55 0.697
Vital status 8 42 0.551
Days to death (days) 599.88 ± 468.76 853.74 ± 806.69 0.395
NA 8 134
Days to last follow-up (days) 876.48 ± 691.48 995.50 ± 952.63 0.501
NA 8 42
Pathologic stage
 Stage I 4 22 0.698
 Stage II 15 74
 Stage III 15 48
 StageVI 6 24
 NA 1 8
Pathology T stage
 T1 2 4 0.757
 T2 4 23
 T3 30 125
 T4 5 24
Pathology N stage
 N0 19 104 0.062
 N1 12 50
 N2 9 22
 NX 1 0
Pathology M stage
 M0 31 120 0.279
 M1 6 24
 MX 3 31
 NA 1 1
  1. A total of 217 clinical samples with RNA-seq data from Broad Institute’s GDAC Firehose were included. The tables compiled the clinical characteristics of CRC in different sites from Broad Institute’s GDAC Firehose